Larry Robbins Biography and Net Worth

Director of CVS Health

Mr. Robbins is the Founder, Portfolio Manager and Chief Executive Officer of Glenview Capital Management. Prior to founding Glenview in 2000, Mr. Robbins spent six years as an analyst and partner at Omega Advisors on their U.S. equity long/short team. He joined Omega after three years at Gleacher & Company, a merger and acquisition advisory boutique in New York. For 30 years, Mr. Robbins has been a portfolio manager analyzing and advising leading publicly traded companies on financial reporting and controls, capital allocation and capital markets strategy and a broad range of governance, operational, communication and strategic issues. Mr. Robbins has been lead independent director and a member of the board of directors of Butterfly Network, Inc., a medical digital imaging company, since 2021. He is also an active supporter of education reform and serves as board member of KIPP NYC, the Relay Graduate School of Education, and Zearn.

Mr. Robbins is recognized as a seasoned investor with deep health care investing expertise. His leadership experience and success in advising companies throughout the health care sector are welcomed by the Board, as well as its Audit and Public Policy and External Affairs Committees.

What is Larry Robbins' net worth?: The estimated net worth of Larry Robbins is at least $472.46 million as of May 20th, 2026. Mr. Robbins owns 5,195,261 shares of CVS Health stock worth more than $472,457,035 as of May 26th. This net worth evaluation does not reflect any other assets that Mr. Robbins may own. Learn More about Larry Robbins' net worth.
How do I contact Larry Robbins?: The corporate mailing address for Mr. Robbins and other CVS Health executives is ONE CVS DR., WOONSOCKET RI, 02895. CVS Health can also be reached via phone at (401) 765-1500 and via email at [email protected]. Learn More on Larry Robbins' contact information.
Has Larry Robbins been buying or selling shares of CVS Health?: During the last ninety days, Larry Robbins has sold $317,473,598.00 in CVS Health stock. Most recently, Larry Robbins sold 370,462 shares of the business's stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $93.45, for a transaction totalling $34,619,673.90. Following the completion of the sale, the director now directly owns 4,824,799 shares of the company's stock, valued at $450,877,466.55. Learn More on Larry Robbins' trading history.
Who are CVS Health's active insiders?: CVS Health's insider roster includes Lisa Bisaccia (EVP), Eva Boratto (Former CFO), Troyen Brennan (EVP), James Clark (SVP), Alexander Cunningham (Exec. VP & COO of Aetna business ), Daniel Finke (EVP), Anne Finucane (Director), Joshua Flum (EVP), Shawn Guertin (Exec. VP & CFO ), Alan Lotvin (EVP), Edward Ludwig (Director), Karen Lynch (EVP), Michael Mahoney (Director), Tilak Mandadi (EVP), Larry Merlo (Director), Thomas Moriarty (EVP), Steven Nelson (EVP), Larry Robbins (Director), Jonathan Roberts (COO), Guy Sansone (Director), Guy Sansone (Director), and Prem Shah (EVP). Learn More on CVS Health's active insiders.
Are insiders buying or selling shares of CVS Health?: In the last twelve months, CVS Health insiders bought shares 1 times. They purchased a total of 1,570 shares worth more than $100,009.00. In the last twelve months, insiders at the pharmacy operator sold shares 5 times. They sold a total of 3,449,051 shares worth more than $324,236,626.58. The most recent insider tranaction occured on May, 21st when Director Larry Robbins sold 370,462 shares worth more than $34,619,673.90. Insiders at CVS Health own 0.9% of the company. Learn More about insider trades at CVS Health.
Information on this page was last updated on 5/21/2026.

Larry Robbins Insider Trading History at CVS Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/21/2026	Sell	370,462	$93.45	$34,619,673.90	4,824,799
5/20/2026	Sell	1,018,000	$93.82	$95,508,760.00	5,195,261
5/19/2026	Sell	1,983,538	$94.45	$187,345,164.10	6,213,261

Larry Robbins Buying and Selling Activity at CVS Health

CVS Health Company Overview

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Today's Range

Now: $90.94

$90.71

$93.51

50 Day Range

MA: $80.73

$69.98

$98.14

2 Week Range

Now: $90.94

$58.50

$98.43

Volume

5,622,736 shs

Average Volume

8,624,321 shs

Market Capitalization

$116.03 billion

P/E Ratio

40.06

Dividend Yield

2.85%

Beta

0.6